According to Compugen's latest financial reports the company's current revenue (TTM) is $33.45 M. In 2022 the company made a revenue of $7.5 M an increase over the years 2021 revenue that were of $6 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $33.45 M | 346.12% |
2022 | $7.5 M | 25% |
2021 | $6 M | 200% |
2020 | $2 M | |
2019 | N/A | -100% |
2018 | $17.8 M | |
2017 | N/A | -100% |
2016 | $0.71 M | -92.33% |
2015 | $9.27 M | -24.98% |
2014 | $12.36 M | 248.46% |
2013 | $3.54 M | 1366.53% |
2012 | $0.24 M | |
2011 | N/A | -100% |
2010 | $1.11 M | 346% |
2009 | $0.25 M | -26.04% |
2008 | $0.33 M | |
2004 | $4.02 M | -54.37% |
2003 | $8.82 M | -20.46% |
2002 | $11.09 M | -2.32% |
2001 | $11.36 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Seagen
SGEN | $2.30 B | 6,775.13% | ๐บ๐ธ USA |
Genetic Technologies GENE | $17.17 M | -48.67% | ๐ฆ๐บ Australia |
Teva Pharmaceutical Industries TEVA | $15.84 B | 47,259.45% | ๐ฎ๐ฑ Israel |
Eterna Therapeutics ERNA | $0.06 M | -99.80% | ๐บ๐ธ USA |